New guidance from the British Menopause Society claims that studies that condemned HRT were “flawed” and the benefits outweigh the risks.
The British Menopause Society has called on GPs to prescribe the drug to any woman suffering with unpleasant menopausal symptoms, such as hot flushes and mood changes.
“Over the last 11 years, HRT has changed from being branded the “elixir of youth” to being considered extremely risky and only to be used in certain circumstances,” a BMS spokesperson said.
The scare began when the WHI study was abandoned three years early as researchers claimed the women were at higher risk of breast cancer, heart disease and strokes.
This contradicted previous – and later – research which suggested it guarded against heart problems.
A year later the MWS study, part funded by Cancer Research, said HRT doubled breast cancer risk. A review last year found this research was “unreliable and defective”.
Professionals are still divided over the use of HRT, with the Royal College of Obstetricians and Gynaecologists continuing to advise that it should only be used for a limited period by women with serious menopausal symptoms
A woman on HRT should be regularly monitored by her GP and once she has been taking HRT for five years, her doctor is expected to discuss the risks before continuing the treatment.
Read the full stories: